The oncogene v-rel of Reticuloendotheliosis virus, strain T, is derived from an avian c-rel proto-oncogene. c-rel encodes a member of the Rel/NF-kB family of transcription factors. The highly oncogenic v-Rel diers from c-Rel which has low transforming potential by the acquisition of numerous mutations. In this manuscript, we demonstrate that the oncogenic mutations in v-Rel directly alter the ability of this protein to bind to DNA. Electrophoretic mobility shift analysis with Rel proteins synthesized in vitro as well as isolated from nuclei of Rel expressing cells showed that three mutation clusters, present in the N-terminus, the center and the C-terminus of v-Rel, altered three dierent aspects of DNA binding. In contrast, the oncogenic C-terminal deletion of 118 amino acids present in v-Rel had almost no in¯uence on its DNA binding. The N-terminal mutation cluster altered the kB DNA-binding speci®city of the v-Rel oncoprotein relative to c-Rel. The mutation Met-20?Thr was found to be principally responsible for this alteration. The second mutation cluster was responsible for increased binding of v-Rel to all the kB sites examined presumably because it stabilized v-Rel homodimers. This alteration in DNA binding was mapped to the group of two mutations within the cluster. In contrast, the third mutation cluster in the C-terminus of v-Rel destabilized the binding of v-Rel to all of the kB sites examined. This is the ®rst indication that regions outside the Rel Homology Region can participate in the control of binding of the c-Rel protein to DNA. The three mutation clusters examined contributed to the tumorigenic potential of v-Rel with the relative strength decreasing with their position from the N-terminus to the C-terminus. These results suggest that the oncogenic mutations in v-Rel cooperate and enable v-Rel to form nuclear complexes with aberrant DNA-binding properties that may directly alter gene expression and DNA replication resulting in the transformation of the cell.
Introduction v-rel is the oncogene of the highly tumorigenic avian retrovirus Reticuloendotheliosis virus, strain T (REV-T) (Bose, 1992; Gilmore et al., 1995) . REV-T induces rapidly growing lymphoid tumors in the spleen and liver of infected galliform birds and solid tumors in their connective tissue (Lewis et al., 1981; Moore and Bose, 1988; Robinson and Twiehaus, 1974) . REV-T originated by the transduction of a turkey c-rel gene by a Reticuloendotheliosis associated virus (REV-A) (Breitman et al., 1980; Hoelzer et al., 1979; Wilhelmsen et al., 1984) . c-Rel is a member of the Rel/NF-kB family of transcription factors (Gilmore, 1990; Kieran et al., 1990) .
Rel/NF-kB proteins participate in the control of cell proliferation, dierentiation and apoptosis (for recent reviews see Baeuerle and Baltimore, 1996; Baeuerle and Henkel, 1994; Baldwin, 1996; Gilmore, 1995; Siebenlist et al., 1994; Verma et al., 1995) . A key mechanism which serves to regulate Rel/NF-kB activity is the interaction of Rel/NF-kB factors with inhibitory proteins called IkB. In many cell types, Rel-NF-kB proteins are held in the cytoplasm associated with their inhibitory proteins in inactive complexes. Following extracellular stimulation IkB is targeted for phosphorylation and subsequently degraded allowing the complexes to move to the nucleus. In the nucleus Rel/NF-kB factors bind as dimers to kB sites (consensus 5'-GGGPuNNPyPyCC-3') located in the promoter and enhancer regions of various eector genes. The eector genes function in defense reponses, regeneration processes and embryogenesis. DNAbound Rel/NF-kB factors are able to both stimulate and repress the transcription of these genes, depending on the sequence context of the kB site and on their interaction with other regulatory factors (Ip, 1995) . There are ®ve vertebrate Rel/NF-kB transcription factors: c-Rel, RelA, RelB, p50 (NF-kB1) and p52 (NF-kB2). They can homodimerize (with exception of RelB) and have the potential to heterodimerize with other family members to achieve distinct patterns of gene expression in dierent cell types. All Rel/NF-kB proteins contain a Rel homology region (RHR), a 300 amino acid sequence which is responsible for dimerization and DNA binding. The N-terminal region of RelB and the C-termini of c-Rel, RelA and RelB contain transactivation domains (Bull et al., 1990; Dobrzanski et al., 1993; Kamens et al., 1990; Schmitz and Baeuerle, 1991) .
v-Rel provides an important model for the understanding of the oncogenic conversion of Rel/NF-kB transcription factors. Several Rel/NF-kB members and their IkB inhibitors have been implicated in the induction of various malignant processes (Fracchiolla et al., 1993; Kabrun et al., 1990; Lewis et al., 1981; Lu et al., 1991; Neri et al., 1991; Ohno et al., 1990) . The cRel proto-oncoprotein itself can be transforming when overexpressed from a retroviral promoter (Abbadie et al., 1993; Diehl et al., 1993; Kralova et al., 1994; Mosialos et al., 1991; Nehyba et al., 1994) . Transformation, particularly of lymphoid cells, by c-Rel is, however, very weak. The transformed cells grow slowly and have a limited life span. The oncogenicity of c-Rel can be increased by deletion of its C-terminus. Mutants of c-Rel with deleted C-termini, apparently selected for higher tumorigenicity, have been isolated from tumors of chickens injected originally with a retrovirus expressing full length c-Rel (HrdlickovaÂ et al., 1994a) . Additionally, several mutants with increased oncogenicity have been constructed by deleting 16 to 118 amino acids from the C-terminus (Capobianco et al., 1990; Diehl et al., 1993; Kralova et al., 1994; Nehyba et al., 1994) . All these truncated variants of c-Rel, however, are far less oncogenic than v-Rel which contains the Cterminal deletion of 118 amino acids as well as 19 additional mutations (Wilhelmsen et al., 1984) (Figure  1b , for de®nition of the term`mutations in v-Rel' see Materials and methods). Also, v-Rel, but not a truncated c-Rel, expressed under the control of the lck promoter, eciently induced malignancies in transgenic mice (Carrasco et al., 1996) . These facts underscore the importance of these additional changes in the amino acid sequence of v-Rel for the oncogenicity of this protein. Indeed, many of these mutations were shown previously to contribute to the eciency of cellular transformation and tumorigenesis by v-Rel (Bhat and Temin, 1990; Diehl et al., 1993; Garson et al., 1990; Hannink and Temin, 1989; HrdlickovaÂ et al., 1994a; Nehyba et al., 1994; Sylla and Temin, 1986) . The mutations are situated in several functional regions of v-Rel (Figure 1a, b) . Two clusters of mutations are located in the Nterminus (N-RH) and C-terminus (RH-C) of the RHR or in immediately adjacent regions. A third cluster of mutations (Trans10) maps to the sequences in the C-terminus of v-Rel with majority of them concentrated in the transactivation region. What functions are, however, in¯uenced by these mutations and what is the relation of these altered functions to tumorigenesis is in large extent unknown. The location of many of the mutations in the RHR makes the binding of Rel to DNA an obvious candidate for a function altered by these mutations.
DNA binding is indispensable for v-Rel transformation because any disruption of its ability to bind DNA abolishes its oncogenicity (Kumar et al., 1992; Morrison et al., 1992; White and Gilmore, 1993; White et al., 1995) . v-Rel is able to bind kB sites and the principal region that provides v-Rel with this ability is the RHR (Kabrun et al., 1991; Kieran et al., 1990; Kochel and Rice, 1992; Morrison et al., 1992; Sarkar and Gilmore, 1993) . Crystallographic analysis performed on p50 (NF-kB1) demonstrated that the RHR consits of two barrel-like domains (Ghosh et al., 1995; MuÈ ller et al., 1995) (see Figure 1a ). These domains are connected by a 10 amino acid linker. DNA is contacted by ®ve loops of each molecule in the Rel/NF-kB dimer. A large number of contacts with DNA by both subunits of a dimer are responsible for the exceptionally high DNA-binding anity of Rel/ NF-kB family member relative to other transcription factors (Baltimore and Beg, 1995; Chytil and Verdine, 1996) . Domain 2, which is located in the C-terminal direction from domain 1, contains the dimerization interface (the site of contact between two molecules in the Rel/NF-kB dimer). Dimerization is indispensable for DNA binding because it not only increases the Figure 1 The functional regions of c-Rel and v-Rel. The functional domains of c-Rel (a), the position of mutations in vRel (b) and the structure of parental and mutant Rel proteins used in this study (c) are shown. (a) the Rel homology region (RHR) consists of two domains D1 and D2 as deduced from the crystallographic analysis of NF-kB1(p50) (Ghosh et al., 1995; MuÈ ller et al., 1995) . The ®ve loops in the RHR that contact DNA directly are indicated by black boxes and numbered above. Loop 1 contains the major DNA recognition motif RxxRxRxxC (Kumar et al., 1992) . A hinge-like loop 3 connects domains D1 and D2. The region¯anking D2 on the C-terminal side (white diagonals on black background) contains the nuclear localization signal indicated by the white box (Gilmore and Temin, 1988) . This¯anking region has not yet been de®ned by crystallography in any Rel/NF-kB protein but its amino acid composition indicates that it is not a part of D2 (Ghosh et al., 1995; MuÈ ller et al., 1995) . Structural as well as functional studies indicate that regions necessary for the formation of Rel/NF-kB dimers are contained in the D2 domain (Bressler et al., 1993; Doerre et al., 1993; Ganchi et al., 1993; Ghosh et al., 1995; Logeat et al., 1991; MuÈ ller et al., 1995) . The region of c-Rel necessary and sucient for inhibition of DNA binding of c-Rel by IkB-a (Beg et al., 1992) is shown (INHIBITION BY IkB-a). Small black boxes identify the amino acids believed to be in contact with IkB-a (Ernst et al., 1995; Ghosh et al., 1995; Kumar and GeÂ linas, 1993) . Two transactivation domains (horizontal line pattern) and a cytoplasmic anchorage region (ANCHORAGE) are shown in the C-terminus (Capobianco et al., 1990; Kamens et al., 1990; Richardson and Gilmore, 1991; Xu et al., 1993) . (b) Mutations in v-Rel are indicated (Capobianco et al., 1990; Hannink and Temin, 1989; Wilhelmsen et al., 1984) . For de®nition of the term mutations in v-Rel' see Materials and methods. The black boxes represent amino acids encoded by env-derived sequences which are fused to the truncated N-or C-termini of c-Rel. The black ellipses identify single amino acid substitutions as well as three small internal deletions. The mutations in v-Rel can be divided into four groups that may aect a similar structural/functional domain: (1) the N-RH mutation cluster contains three amino acid substitutions as well as the N-terminal deletion of two amino acids of c-Rel and the insertion of 11 viral env amino acids (with three amino acid dierences compared to REV-A env (Bhat and Temin, 1990) ), (2) the RH-C cluster of mutations contains four amino acid substitutions in the C-terminal region of the RHR, (3) a group of mutations, designated Trans10, contains 6 amino acid substitutions, three internal deletions of one or two amino acids and the addition of 18 amino acids encoded by out-of-frame env sequences at the truncated C-terminus and ®nally (4) a large deletion of 118 amino acids (D118) of the original c-Rel Cterminus. The RHR is indicated by the darker pattern while the less conserved regions in the N-and C-terminal regions of the protein are in the lighter pattern. (c) The protein structure of the mutant Rel proteins derived from parental c-Rel and v-Rel are shown. The names of speci®c Rel proteins and retroviruses used for the expression of these proteins in cell culture and in animals are on the right side of the ®gure. All retroviral stocks were produced with the CSV helper virus number of contacts but also locks the structure of the two RHRs that encircle the DNA double helix (Baltimore and Beg, 1995; Chytil and Verdine, 1996; Siebenlist et al., 1994) . The positions of ®ve amino acids which are mutated in v-Rel's RHR can be localized in the known crystal structure of the RHR of p50 (NFkB1). These mutated amino acids do not directly contact DNA nor are they on the dimerization interface. This is not surprising because any change of a highly conserved amino acid which is directly responsible for contact with DNA or for dimerization would probably abolish and not simply modify the DNA-binding function of the protein.
Three important ®ndings suggest that some of the mutations in v-Rel may indeed have a role in its DNAbinding ability. First, v-Rel containing protein complexes in ®broblasts are inherently more resistant to the inhibition of DNA binding by IkB-a than complexes containing overexpressed c-Rel (Diehl et al., 1993) . Secondly, DNA binding by v-Rel is more resistant to mutations introduced experimentally into the conserved protein kinase A recognition sequence than cRel (Mosialos and Gilmore, 1993) . Both of these properties were associated with a large group of 10 mutations representing a majority of the RH-C and Trans10 clusters. Finally, oncogenic mutations in v-Rel in¯uence the properties of kB-binding complexes present in nuclei of v-Rel-transformed cells (HrdlickovaÂ et al., 1995a) . However, despite this evidence the direct in¯uence of the v-Rel mutations on its DNA binding has not been de®ned.
To directly de®ne the role of the mutations on the dierence in DNA binding between v-Rel and c-Rel we introduced three mutation clusters (and the C-terminal deletion of 118 amino acids) in dierent combinations into c-Rel. Electrophoretic mobility shift assays (EMSAs) with these Rel chimeras translated in vitro as well as with nuclear extracts from Rel expressing cells demonstrated that the mutations in all three clusters present in v-Rel alter the ability of c-Rel to bind to kB sites. Transformation assays showed that all these mutation clusters also contribute to tumorigenicity of v-Rel.
Results
Three clusters of mutations in v-Rel are responsible for the dierence in the kB DNA-binding activities of v-Rel and c-Rel v-Rel diers from the proto-oncoprotein c-Rel in 20 mutations (Figure 1b) . Nine of these mutations (out of twelve studied) have been shown to be oncogenic (Bhat and Temin, 1990; Garson et al., 1990; HrdlickovaÂ et al., 1994a) . To de®ne how the mutations in v-Rel contribute to its oncogenicity, we evaluated the eect of the mutations in v-Rel on its DNA-binding ability. Mutations in v-Rel can be divided into three mutation clusters (N-RH, RH-C, Trans10) and the deletion which removed 118 C-terminal amino acids of c-Rel (D118). Each group of mutations is located in dierent functional region of v-Rel (or c-Rel). To de®ne how these dierent groups of mutations in¯uence the DNAbinding activity of v-Rel, a set of eight gene constructs which express v-Rel/c-Rel-hybrid proteins were prepared ( Figure 1c ). Six hybrid proteins (tcc-Rel, ctc-Rel, ttc-Rel, ctt-Rel, tct-Rel, cct-Rel) were fusion proteins containing three regions of v-Rel and the corresponding regions of c-Rel arranged in all possible combinations (see Figure 1c) . Two additional proteins (cRelD118 and ttc-RelD118) were derived from c-Rel and ttc-Rel, respectively, by deleting 118 amino acids from the C-terminus.
The kB DNA-binding properties of the parental (cRel and v-Rel) and the hybrid Rel proteins were analysed by electrophoretic mobility shift assays (EMSAs) (Figure 2a ). Rel proteins were synthesized in a coupled in vitro transcription/translation system and the products of synthesis were veri®ed by SDSpolyacrylamide gel electrophoresis (SDS ± PAGE) (Figure 2c ). Three distinct kB sites were employed for the EMSA. The ®rst site, the c-rel kB sequence GGGAAATTCC, is present in the promoters of chicken c-rel Hannink and Temin, 1989) , the human b interferon gene (see references in Baeuerle, 1991) and the mouse IP-10 gene (Ohmori et al., 1994) . The second kB site employed, GGGGGTTCCC, is present in the enhancer A regulatory unit of the chicken major histocompatability complex (MHC) class I promoter (Kroemer et al., 1990) . The third kB sequence evaluated was GGGAATTCCC. This sequence is a palindromic variant of the human IL-2R kB site (IL-2R kB-pd) (Ballard et al., 1990) and is found in the promoter of human nfkb2 (Liptay et al., 1994) .
EMSAs revealed that each dierent Rel protein bound DNA in two types of complexes: in a rapidly migrating complex which was usually the most abundant (designated as primary complex) and in low mobility complexes near the top of the gel (Figure 2a ). The complexes formed by distinct parental and chimeric Rel proteins with kB DNA displayed dierent patterns and contained dierent amounts of bound DNA. Three DNA-binding patterns were detected depending on the Rel protein employed in the EMSA (Figure 2b ). Each Rel protein formed complexes of the same pattern with all three kB oligonucleotides examined (Figure 2a ). The pattern detected did not depend on the ratio of the Rel protein and kB DNA used in the binding reaction. The pattern of complexes formed correlated with the presence or absence of the mutation clusters RH-C and Trans10. Proteins with the RH-C mutation cluster and lacking the Trans10 mutations (ctc-Rel, ttc-Rel, ttc-RelD118) produced primary complexes of a uniform mobility (Figure 2, lanes 4, 5, 11 ). The homogeneity of these complexes was best visible at low intensity ( Figure 2a , lane 4 ± MHC class I kB probe, Figure 2b , lanes 4, 5, 11). Very low amounts of the DNA-binding activity (relative to the DNA-binding activity present in homogenous complexes) were detected in low mobility complexes (Figure 2, lanes 4, 5, 11 ). In contrast, proteins with the Trans10 mutations which lacked the RH-C mutation cluster (tct-Rel, cct-Rel) produced heterogeneous primary complexes visualized as widely diuse bands of low intensity (Figure 2, lanes 8, 9) . When higher amounts of the labeled oligonucleotide were used in the EMSA, the diuse bands were resolved into several distinct complexes (data not shown). Moreover, large amounts of the DNA- The exposure of the free probe is eight times shorter than the exposure of the bound probe. The bound probe was present in two distinct complexes: a rapidly migrating complex which was usually the most abundant complex (designated primary complex) and a low mobility complex near the top of the gel (indicated by LMC on the left side of the gel). Free probes were resolved by EMSA polyacrylamide gels into three closely migrating species where only the slowest migrating species (de®ned as the active probe and indicated by the arrow on the left side of the gel) was able to bind to the Rel proteins ± see Materials and methods for further comments. The amounts of the active probe used for the binding reactions, retrospectively determined by measuring the active probe species in the lane 1, diered between the three probes used. The calculated quantities of active probe are indicated by the relative numbers on the left side of the gel. The amount of active probe bound and shifted by Rel proteins did not exceed 32% of the total active probe used for particular experiment. All of the DNA-binding activity detected in these assays were the result of speci®c binding. The speci®city was veri®ed as described in Materials and methods. The probe bound in the primary complexes was supershifted by anti-Rel antiserum VI (data not shown). S-labeled proteins was used to de®ne the yield of unlabeled proteins synthesized in a parallel reaction. Unlabeled proteins were used for the EMSA asays. On the left side of the ®gure molecular weight markers are shown. All of the proteins with the 118 amino acid C-terminal deletion gave one major band with a mobility corresponding to approximately 59 kDa (lanes 1 ± 6). Proteins with the complete C-terminus of c-Rel gave two major bands of approximately 68 and 70 kDa (lanes 7 ± 10). The slower migrating (70 kDa) band disappeared after treatment with bacterial alkaline phosphatase; while the faster (68 kDa) band simultaneously increased in intensity (data not shown) suggesting that the upper band represents a phosphorylated form of the protein. Similar 70 kDa proteins were observed in vivo as well (HrdlickovaÂ et al., 1995b) indicating that phosphorylation of c-Rel in the wheat germ extract system may not be an artifact. Quantities of the Rel proteins shown on the Figure correspond to those used for the EMSAs with the exception of c-Rel which was loaded on a SDS-polyacrylamide gel at 0.756lower concentration binding activity were detected in the low mobility complexes close to the top of the gel (for example see Figure 2b , lanes 8, 9). A third pattern of complex formation ( Figure 2 , lanes 2, 3, 6, 7, 10) was observed for proteins containing both the RH-C and the Trans10 mutations or alternatively those without either the RH-C and the Trans10 mutations . The homogeneity of the most abundant complex and the intensity of the low mobility complexes were intermediate. For future reference we will designate the three patterns as pattern I (focused), II (intermediate) and III (diuse). The Cterminal deletion of 118 amino acids had no signi®cant eect on the DNA-binding pattern ( Figure 2a , b ± compare lanes 2 and 5 with lanes 10 and 11, respectively).
The amount of the DNA bound by each of the Rel proteins was also dierent as indicated by the relative intensity of the labeled complexes. The bound DNA shown in Figure 2 was quanti®ed by a Phosphorimager 445SI (Molecular Dynamics) and results are presented in Table 1 . To further substantiate the dierences in the DNA-binding activities of parental and chimeric Rel proteins we also measured complex formation of the Rel proteins with two DNA probes at four dierent probe:protein ratios (Figure 3 ). The Table 1 DNA binding of in vitro translated Rel proteins. Quantitative evaluation of the probe bound in primary (PC) and low mobility complexes (LMC) in the experiment shown in Figure 2 kB DNA probe bound in complexes with Rel proteins c-relkB IL-2R The amount of bound 32 P-labeled kB DNA probe was determined by a Phosphorimager 445SI (Molecular Dynamics). The amount of the probe bound in the primary complex is shown in relative Phosphorimager units (rPU). The table presents corrected values for the c-rel kB and the MHC class I kB bound probe. The original data obtained from Phosphorimager were divided by 1.7 and 1.1, respectively, to compensate for higher amounts of active probe used in the binding reactions with the c-rel kB and the MHC class I kB oligonucleotides in comparison with reactions that contained the IL-2R kB -pd oligonucleotide. The amount of the probe bound in the low mobility complex is presented as a % of the probe bound in the primary complex Figure 3 Complex formation of in vitro generated Rel proteins with two kB DNA probes at four dierent probe:protein ratios. This graph de®nes the amount of DNA bound in the EMSAs quantitated using a Phosphorimager 445SI (Molecular Dynamics). Only the DNA bound in the primary complexes was measured. The results are expressed in relative Phosphorimager units (rPU) and were not calibrated to be comparable in absolute values to those shown in Table 1 . The same set of Rel proteins (from an independent in vitro synthesis) was used as shown in Figure 2 . The proteins are represented in the graphs by the following symbols:
Each binding reaction contained 0.5 fmol of unlabeled Rel protein and one of the four concentrations (25 000, 50 000, 100 000, 200 000 c.p.m. per binding reaction volume) of the two probes, either the IL-2R GGGAATTCCC kB-pd probe or the MHC class I GGGGGTTCCC kB probe. The calculated relative quantities of active probe determined by measuring the active probe species in the binding reaction with mock in vitro translated wheat germ lysate were 1.0 for the IL-2R kB-pd probe and 1.6 for the MHC class I kB probe results demonstrated an almost linear increase in the amount of the probe bound in the primary complex when the amount of the total labeled DNA was changed over the range of 1-2-4-8. The detected dierences in the DNA binding by distinct Rel proteins are, therefore, not likely to be in¯uenced by the protein:DNA ratio used in the EMSA. To determine how the mutations in¯uence the amount of DNA bound in the primary complexes we compared the amount bound by Rel proteins containing speci®c mutation clusters (or C-terminal deletion) with the amount bound by their counterpart lacking these mutations (Table 2) . Table 2 shows that the presence or absence of the N-RH mutation cluster determined the distinct DNAbinding speci®cities of the various Rel proteins for the three kB sites evaluated. Proteins containing the N-RH mutations (tcc-Rel, ttc-Rel, v-Rel and tct-Rel) bound 2 ± 46more to the MHC class I kB site, equally well to the IL-2R kB-pd site and 26less to the c-rel kB site as their respective counterparts containing an unmutated N-terminus (c-Rel, ctc-Rel, ctt-Rel and cct-Rel) (compare also in Figure 2a lanes 3, 5, 6 and 8 with lanes 2, 4, 7 and 9, respectively). The binding of each speci®c Rel protein to the MHC class I kB site showed (for unknown reasons) much higher variability among dierent experiments than the binding to the IL-2R kB-pd site. In contrast to the N-RH mutations, the RH-C and Trans10 mutations altered the amount of DNA bound by the Rel proteins equally for all three kB sites. The RH-C mutations increased the kB DNA binding approximately twofold (1.6 ± 2.86) while the Trans10 mutations decreased the binding 2.56 (Table 2) Table 1 ). In contrast to the three mutation clusters, the C-terminal deletion of 118 amino acids had no signi®cant eect on the amount of DNA bound in the primary complex.
The amount of DNA bound by the various Rel proteins as shown in Table 2 did not include the DNA present in the low mobility complexes. The use of total bound DNA (DNA in primary and low mobility complexes) changed signi®cantly only the results regarding the Trans10 mutation cluster. The Trans10 + proteins bound in both of these complexes 80% of the probe bound by their Trans10 7 counterparts (in contrast to 40% when only primary complexes were considered). The analysis of DNA bound in the low mobility complexes (Table 1) revealed also the only signi®cant DNA-binding eect of the deletion of the 118 C-terminal amino acids: ttcRelD118 bound in low mobility complexes about 2 ± 36less DNA than ttc-Rel.
Taken together, the oncogenic mutations located in three dierent functional regions of c-Rel strongly in¯uenced the DNA-binding abilities of the mutated Rel proteins. The oncogenic mutations in domain 1 of the RHR altered the kB DNA-binding speci®city. Oncogenic mutations in domain 2 of the RHR and in the region of the nuclear localization signal increased the binding equally to all three kB sites tested and concomitantly changed the pattern of DNA-binding complexes in the EMSA to more homogeneously migrating complexes. The oncogenic mutations found in the C-terminus of v-Rel reduced the DNA-binding anity equally to all three kB sites evaluated and resulted in a more heterogeneous pattern of complex formation. 
This Table compares the amount of probe bound by the Rel protein with the speci®c mutation cluster to the amount of the probe bound by the corresponding reference Rel protein that diers from the ®rst one by absence of this cluster. The percentage values for bound c-rel kB probe presened in this table were generated using the results of the experiment decribed in Figure 2 and Table 1. The percentage values for the other two bound probes were calculated using in addition data from the experiment described in Figure 3 (four measurements, each with the dierent amount of total probe); these percentage values are, therefore, presented as mean+standard error of mean of ®ve measurements. The probe bound in low mobility complexes was not included in the calculations of percentage values presented in this table kB DNA-binding activity of oncogenic Rel proteins in the cell nucleus To de®ne whether the various oncogenic Rel proteins synthesized in vivo have the same distinct DNA-binding properties as proteins generated in vitro, we evaluated the DNA-binding activity of the Rel proteins isolated from DT95 cells. DT95 cells were infected by REV-rel (CSV) viruses (REV based viruses with chicken syncytial helper virus) which expressed v-Rel, ctt-Rel, tct-Rel, cct-Rel, c-RelDv118 and ttc-RelDv118. These proteins contained the C-terminal deletion of 118 amino acids and the various combinations of the mutation clusters present in v-Rel. Analysis of nuclear extracts obtained from retrovirus-infected DT95 cells two days after infection (Figure 4a ) revealed one (lane 6) or two (lanes 2, 3 and 7) major kB DNA-binding complexes (the complexes are indicated by arrows and numbers 1 and 2 on the right side of the ®gure). Very heterogeneous complexes of a diuse pattern were present in the nuclear extracts from cells expressing tctRel and cct-Rel (lanes 4 and 5). Supershift analysis showed that the major complexes contained retrovirus expressed full length Rel proteins (for v-Rel see Figure  5 ± lanes 2 ± 4, for other Rel proteins data not shown). Almost all of the kB DNA-binding complexes were supershifted by V1 antiserum against the C-terminus of the RHR of v-Rel and the complexes from v-Rel, tctRel and ttc-RelD118 expressing cells were supershifted by 1647 antiserum against the N-terminal env epitope of v-Rel. The major complexes in v-Rel, ctt-Rel, tctRel and cct-Rel expressing cells were also supershifted by VC antiserum against the C-terminal env encoded epitope of v-Rel. Antiserum against the C-terminus of v-Rel failed to supershift complexes with mobility intermediate between complex #1 and #2 and minor complexes that migrated faster than complex #2. These faster migrating minor complexes may contain Rel proteins with deletions in their C-terminus.
The mobility of the major complexes was compared with the mobility of DNA-binding complexes of in vitro synthesized Rel proteins (indicated in Figure 4a by the arrow on the left side). The complexes that comigrated with DNA bound in vitro translated Rel proteins were presumed to represent homodimers of the oncogenic Rel proteins (Figure 4a , the complex #1 in lanes 2, 3, 6 and 7 and these heterogeneous complexes in lanes 4 and 5 that migrated as fast as or slower than complex #1). The homodimeric nature of these complexes is further supported by the fact that none of these complexes were supershifted by speci®c antisera against c-Rel, NF-kB1 (for v-Rel see Figure 5 ) and RelA (data not shown) the three Rel/NF-kB members which have the potential to heterodimerize with v-Rel. A supershifted band was observed 
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7 proteins (tct-Rel, cct-Rel) formed heterogeneous nuclear complexes that closely resembled those formed by their in vitro translated counterparts (pattern III ± diuse). The relative amount of probe bound in the low mobility complexes near the top of the gels paralleled the amount of probe bound in these complexes by in vitro synthesized proteins (compare Figure 4a, lanes 2, 3, 4 , 5, 6 and 7 with Figure 2a, lanes  6, 7, 8, 9, 10 and 11 ). These observations demonstrated that the distinct patterns of the Rel-kB DNA complexes (determined by the RH-C or the Trans10 mutations) seen with in vitro translated proteins were also observed with proteins in nuclear extracts.
The DNA-binding patterns of in vivo synthesized proteins were also associated with the distinct ability to bind DNA in a fashion analogous to the experiments with in vitro generated proteins. The Trans10 mutations decreased the amount of DNA bound by the Rel proteins (Figure 4a , compare lane 7 (ttc-RelD118) with lane 2 (v-Rel) and lane 6 (c-RelD118) with lane 5 (cctRel)). To demonstrate, that the RH-C mutations increased the amount of DNA bound by the Rel proteins in vivo as they did in vitro, one should compare the total DNA bound by both #1 and #2 complexes containing v-Rel and ctt-Rel (lanes 2 and 3) with the heterogeneous complexes of tct-Rel and cctRel (lanes 3 and 4) . The complexes #2 were not supershifted by speci®c antisera against the four cellular Rel/NF-kB members (mentioned above) and may represent either DNA bound homodimers of the full length Rel proteins containing certain modifications that increased their mobility in EMSA or heterodimers' of full length Rel and Rel with a short C-terminal deletion.
The N-RH mutations altered the DNA-binding speci®city of the Rel complexes in nuclear extracts from DT95 cells in a fashion analogous to the altered DNAbinding speci®city observed with in vitro synthesized proteins. The ratio of the amount of probe bound by the Rel proteins containing the N-RH mutations (v-Rel, tctRel) versus the probe bound by proteins with the wild type N-terminus (ctt-Rel, cct-Rel) was always lower for the IL-2R kB-pd site than for the MHC class I kB site (Figure 4a , compare v-Rel with ctt-Rel and tct-Rel with cct-Rel). This agrees with our previously published results (HrdlickovaÂ et al., 1995a) .
In contrast to the various mutation clusters, the deletion of 118 C-terminal amino acids did not alter the DNA-binding activity of in vivo synthesized c-Rel. Complexes of an identical mobility, DNA-binding pattern and DNA-binding speci®city were detected in nuclear extracts from both the c-RelD118 expressing cells (Figure 4a , lane 6) and c-Rel expressing cells examined at the same time point (data not shown).
The three mutation clusters that alter the DNA binding of v-Rel contribute to v-Rel's oncogenicity with the relative strength decreasing with their position from the N-terminus to the C-terminus
The three mutation clusters present in v-Rel alter its DNA binding relative to c-Rel. To de®ne the relative contribution of each of these three clusters to the tumorigenic potential of v-Rel, chickens were injected with Rev-rel(CSV) retroviruses: REV-TW, REV-CTT, REV-TCT and REV-TTCD118. These viruses expressed v-Rel, ctt-Rel, tct-Rel and ttc-RelD118, respectively. The control birds were injected with chicken syncytial virus (CSV). The chickens were sacri®ced at the time at which the ®rst external pathological signs were apparent. Only REV-TW infected chickens exhibited a signi®cant decrease in body weight in comparison with control CSV infected chickens (Table 3) . Macroscopically detectable tumor foci were found in the liver of 71% of the REV-TW infected birds and 17% of the REV ± TTCD118 infected birds. Chickens infected with REV-TW, REV-TTCD118 and REV-TCT showed signi®cant splenomegaly when compared with CSV infected chickens ( Figure 6a , Table 3 ). These three viruses induced splenomegaly in decreasing order. Spleen weights correlated with the presence of macroscopically detectable tumor foci. Tumor foci were found in the spleens of all REV-TW and REV-TTCD118 infected birds, 71% of the REV-TCT infected birds and 14% of the birds infected with REV-CTT ( Table  3) . The in vitro growth potential of splenic tumor cells from chickens infected with each viral chimera was also analysed and the number of tumor colony forming units (tCFU) per spleen was calculated (Figure 6b ). The number of colony forming units in the spleens of virus infected birds paralleled the ability of these viruses to induce splenomegaly and tumor foci in both the spleen and liver. The tCFU/spleen (or tCFU/ mg of splenic tissue) was highest in spleens obtained from birds infected with REV-TW and lowest in spleens of REV-CTT infected birds. Both the in vivo tumorigenic and in vitro colony formation studies, therefore, indicate that all three mutation clusters in v-Rel contribute to its oncogenic potential. Mutations in the N-terminal region of the RHR of v-Rel constitute the principal oncogenic mutation cluster, while the mutation cluster in the transactivation domain makes the least contribution. The contribution of the C-terminal deletion of 118 amino acids to the tumorigenic potential of v-Rel was not evaluated because this mutation did not in¯uence v-Rel's binding to DNA. Previous studies suggested that restoration of c-Rel's C-terminus to v-Rel does not signi®cantly decrease its oncogenicity (Hannink and Temin, 1989; Sylla and Temin, 1986) . However, because the deletion of 118 C-terminal amino acids increases tumorigenic potential of c-Rel (HrdlickovaÂ et al., 1994a and unpublished data) the deletion could play an important role during the evolution of v-Rel's oncogenicity.
Alteration in kB DNA-binding speci®city of v-Rel was mapped to the mutation Met-20?Thr of the N-RH cluster while the nonspeci®c increase in kB DNA binding was mapped to the group of two amino acid substitutions within the RH-C cluster Mutations in the N-terminus of v-Rel (N-RH cluster) were found to be the principal mutations which increased the transformation eciency of v-Rel relative to c-Rel (Nehyba et al., 1994 and this work) . The N-RH cluster consists of several mutations: a deletion of the N-terminus of c-Rel, its replacement with sequences derived from REV-A env and the three amino acid substitutions (designated in this manuscript a, b, c) located in domain 1 of the RHR (Figure 7a) . Replacement of c-Rel's N-terminus by env encoded amino acids and each of the three amino acid substitutions were shown to be oncogenic (Bhat and Temin, 1990; Garson et al., 1990; HrdlickovaÂ et al., 1994a) . To de®ne whether these mutations constitute a functional group which alters v-Rel's DNA-binding speci®city, ®ve additional c-rel mutants were constructed which encoded the following mutant proteins: envc-Rel, c-Relabc, c-Rela, c-Relb and c-Relc (Figure 7a ). The DNA-binding speci®cities of these mutant Rel proteins as well as c-Rel were determined by EMSA (Figure 7b Mutations in the C-terminus of the RHR of v-Rel (RH-C cluster) contributed signi®cantly to the transformation eciency of v-Rel as well. Therefore, we also wanted to determine if all four amino acid substitutions in this cluster constitute a functional group which increases the binding of v-Rel equally to all three kB sites. Two additional c-rel mutants were used that encoded mutant proteins designated c-Relde and c-Relgi (Figure 7a ). EMSA showed that the altered DNA-binding activity caused by the RH-C mutation cluster can be mapped to the cluster of two amino acid substitutions d and e (Figure 7b , lanes 8 ± 11). genes during evolution from proto-oncogene predecessors modi®ed transcriptional regulatory functions of their protein products. The aberrant function of oncoproteins alters the expression of target genes and some of these genes may then be responsible for the epigenetic changes which convert a normal cell into a tumorigenic cell (Lewin, 1991) . In order to understand the changes in the transcription of target genes, the aberrant functions of the oncoproteins must be determined. Theoretically, several functions may be altered in the v-Rel oncoprotein relative to c-Rel, including DNA binding, ability to activate transcription, susceptibility to their inhibitors, cytoplasmic/ nuclear transport and the interaction with other transcription factors. v-Rel has been shown previously to dier from c-Rel in the ability to transactivate gene expression, in susceptibility to its inhibitor IkB-a and in cytoplasmic/nuclear localization (Capobianco et al., 1990; Diehl et al., 1993; HrdlickovaÂ et al., 1994b; Richardson and Gilmore, 1991) . In this manuscript we provide the ®rst comprehensive review of the differences in the DNA-binding abilities between v-Rel and c-Rel. We demonstrated that the three oncogenic mutation clusters in v-Rel (N-RH, RH-C and Trans10) altered three dierent aspects of the kB DNA-binding properties of the Rel protein.
N-RH mutations
The oncogenic mutations in the N-RH cluster changed the DNA-binding speci®city of the Rel proteins. In our assays c-Rel bound strongly to kB sites with four to ®ve internal A/T bases¯anked by G/C containing nucleotides (c-rel kB, IL-2R kB-pd) and weakly to the kB site from MHC class I promoter that contained only two internal A/T bases. The oncogenic mutations located in the N-terminus of v-Rel selectively increased the binding of the mutated c-Rel to the MHC class I kB site. The same change in DNA-binding speci®city was also demonstrated with oncogenic Rel proteins extracted from nuclei of Rel expressing cells. The strong binding of v-Rel and the poor binding of c-Rel to the kB site in the MHC class I promoter (which does not conform to the NGGNNPyTTCC, human cRel binding consensus kB site (Kunsch et al., 1992) ) suggests that the DNA-binding speci®city of v-Rel might be changed to resemble other kB DNA-binding proteins. In this respect, the situation is similar to the oncogene v-erbA. The DNA-binding speci®city of verbA is distinct from that of c-erbA, the thyroid hormone receptor and resembles the DNA-binding speci®city of the retinoic acid receptor (Chen et al., 1993) . Further analysis revealed that the alteration in the kB DNA-binding speci®city of v-Rel can be ascribed to a group of three oncogenic amino acid substitutions in v-Rel: Met-20?Thr, Asp-82?Gly, Arg-97?Gln. The mutation Met-20?Thr was the principal mutation that changed the DNA-binding speci®city. This mutation was shown previously to signi®cantly contribute to the oncogenicity of v-Rel (Bhat and Temin, 1990) . Met-20?Thr is located in the major DNA recognition loop in the RxxRxRxxC binding motif of v-Rel (Kumar et al., 1992) . This mutation resides in one of the four amino acid sequence positions demonstrated to be important in de®ning the dierence in the DNAbinding speci®city of human RelA and p50 (NF-kB1) (Coleman et al., 1993; Toledano et al., 1993) . Interestingly, it is only 10 amino acids from the mutation Ala-31?Ser, which was identi®ed in a vRel mutant with higher transformation eciency for Bcells (Romero and Humphries, 1995) . The mutation Ala-31?Ser resides in another of the four amino acid sequence positions which control the DNA-binding speci®city of human RelA and p50 (NF-kB1). It was shown that this mutation increases the ability of v-Rel to bind to human IL-2 kB site, but the possibility that it may change the DNA-binding speci®city of v-Rel was not investigated.
The other mutations in the N-RH cluster (replacement of two N-terminal amino acids of c-Rel by 11 amino acids encoded by env-derived sequences) were also shown to contribute to the oncogenicity of v-Rel (Bhat and Temin, 1990; Garson et al., 1990) . These mutations, however, did not in¯uence the kB DNAbinding properties of the Rel proteins. It is possible that the fusion of c-rel with the env gene may have altered functions of c-Rel other than its DNA-binding activity (transcription/translation eciency, the stability of the protein or other functions).
RH-C and Trans10 mutations
The oncogenic mutations in the RH-C cluster increased the binding of the Rel proteins to all the kB sites evaluated. The results suggest that mutations Arg-250?Gly and Glu-269?Ala are responsible for this eect (it needs to be determined if both of these mutations or just one of them contribute to the eect). The Arg-250?Gly and Glu-269?Ala substitutions are found in domain 2 of the RHR. Based on the crystal structure of p50 (NF-kB1) (Ghosh et al., 1995; MuÈ ller et al., 1995) , these amino acids do not contact DNA or interact directly with the dimerization interface. However, it is possible that they in¯uence the overall conformation of the dimerization interface and indirectly increase the stability of Rel dimers bound to DNA. This may explain both the increase in DNA binding to all the kB sites tested and the homogeneity of the DNA bound complexes when the Rel proteins contained the RH-C mutations. Furthermore, the stabilization of dimers bound to DNA are consistent with the increased resistance of v-Rel to the eect of linker insertion mutagenesis in the region of the kinase recognition site (RRPS) relative to c-Rel (Mosialos and Gilmore, 1993) . Mutagenized v-Rel in those studies was found to form dimers more eciently than mutagenized c-Rel. It was previously reported that vRel containing cellular complexes are more resistant to the inhibition of DNA binding by IkB-a than the complexes containing c-Rel (Diehl et al., 1993) . It is possible that stabilization of the Rel-DNA complex by the RH-C mutations is the underlying cause for this resistance. Indeed, our preliminary results indicate that in vitro generated Rel proteins with the RH-C mutation cluster are more resistant to the IkB-a mediated inhibition of DNA binding in vitro than their respective counterparts without this mutation cluster.
Mutations in the C-terminus of v-Rel outside of the RHR (Trans10 cluster) were found to have an opposite eect on the DNA-binding activities of Rel homodimers than the RH-C mutations. Trans10 mutations decreased the binding of Rel to all the kB sites tested and were responsible for a more diuse pattern of DNA-binding complexes in EMSA. These eects can be explained as a destabilization of Rel dimers bound to DNA resulting in their decreased ability to bind DNA and increased potential to assume several dierent conformations in the complexes with DNA (seen in EMSA as diuse pattern composed, in fact, from several bands). Interestingly, functional properties of the Trans10 mutation cluster indicate that regions in the C-terminus of c-Rel (and may be analogous regions in RelA and RelB) can contribute to the control of DNA binding. So far only the RHRs were credited with an ability to control DNA binding of c-Rel, RelA and RelB (Gilmore, 1995; Siebenlist et al., 1994) .
The homodimeric Rel-DNA complexes in the nuclei of Rel expressing DT95 cells had the same distinct DNA-binding patterns observed with in vitro translated proteins. This strongly suggests that the DNA-binding properties controlled by the RH-C and Trans10 mutations are properties of natural proteins and not an artifact of in vitro synthesis. The opposite eects of the two oncogenic mutation clusters RH-C and Trans10 on DNA binding of v-Rel are, however, perplexing. Several explanations can be proposed. Conditions for the DNA binding in the EMSAs may not mimic precisely the conditions in the cell nucleus. The DNA-binding eects of both mutation clusters may be under additional control in vivo or these two eects can be expressed dierently under certain situations. For example, posttranslational modifications or interactions with other molecules may control the negative eect of Trans10 mutations on DNA binding. Alternatively, it is possible that Trans10 mutations may decrease the binding of v-Rel homodimers more than the binding of v-Rel heterodimers containing cellular Rel/NF-kB proteins. An additional possibility is that the RH-C or the Trans10 mutation clusters may play a role in transformation other than DNA binding. For example, the transactivation domain of v-Rel was mapped to a region that overlaps with the Trans10 mutation cluster and transactivation ability was shown to correlate with transformation by v-Rel (Sarkar and Gilmore, 1993) .
Relation between DNA-binding function and the gene induction/repression potential of the three mutation clusters present in v-Rel Several Rel/NF-kB target genes are either up or downregulated as a consequence of v-Rel's expression Carrasco et al., 1996; HrdlickovaÂ et al., 1994b HrdlickovaÂ et al., , 1995b Kralova et al., 1994; Zhang et al., 1995; Zhang and Humphries, 1996) . The expression of several of these genes (MHC class I and II, IL-2R) were shown to be activated to a higher extent by v-Rel than c-Rel (HrdlickovaÂ et al., 1994b , Nehyba et al., 1994 . Because these genes or their mammalian homologs contain kB sites in their regulatory regions it was proposed that v-Rel may regulate expression of these genes by directly interacting with their kB sites. However, both v-Rel and c-Rel are able to bind kB DNA and the most active transactivation domain of vRel has been deleted (Richardson and Gilmore, 1991) . Therefore, one may suppose that there are other important functional changes in v-Rel controlled by the oncogenic mutations that compensate for the loss of the transactivation domain and which increase the gene activation potential of v-Rel. The dierences in the binding of v-Rel and c-Rel to kB sites may be partly responsible for v-Rel's altered activation potential.
We have previously shown (Nehyba et al., 1994 ) that proteins containing the RH-C mutation cluster (v-Rel, ttc-Rel) induce the expression of MHC class I and class II proteins more eectively than Rel proteins lacking these mutations (tct-Rel, tcc-Rel). These RH-C + proteins also bind to the kB sites more eciently than the corresponding RH-C 7 proteins (Figure 2 , Table 2 (Nehyba et al., 1994) is complicated by the strong cytotoxicity/ cytostaticity of ctc-Rel. Cell expressing ctc-Rel almost stopped dividing which may explain why the MHC proteins were induced in ctc-Rel expressing cells to a lesser extent.
Future studies need to be performed to directly address the question whether the dierential binding of Rel proteins determined by EMSAs is re¯ected by their transactivation/repression activity on the promoters of cellular genes. We have performed cotransfection experiments where the promoter-regulatory activities of the chimeric Rel proteins were measured in chicken embryonic ®broblasts (CEFs) using constructs with the IL-2R kB-pd and MHC class I kB sites fused to a minimal SV40 promoter driving the luciferase reporter gene (data not shown). Expression of v-Rel or any of the chimeric Rel proteins with the C-terminal deletion of 118 amino acids partially repressed the activity of the promoter with kB sites. The extent of repression, however, did not correlate either with DNA-binding activity nor with transformation potential of the expressed Rel proteins (that agrees with previously published data (Sarkar and Gilmore, 1993) ). Moreover, the Rel proteins also repressed the activity of the minimal SV40 promoter without kB sites. This experiment demonstrated that the action of v-Rel on promoters also involves kB-independent interactions (as already shown previously (Sif and Gilmore, 1994) ) and is, therefore, very complex even when a simple reporter system is employed. Additional modi®cation of the reporter system will be needed to obtain results which de®nitely show how dierent EMSA-detected kB DNA-binding properties of v-Rel and c-Rel in¯uence their promoter regulatory activities.
Relation between DNA-binding function and the oncogenic potential of the three mutation clusters present in v-Rel
The three mutation clusters in v-Rel that in¯uenced distinct aspects of DNA binding by v-Rel contributed in dierent degrees to its oncogenicity. The current data, however, do not allow one to de®ne if there is a quantitative correlation between the change in DNA binding due to the mutation clusters and transformation potential of mutant Rel proteins. First of all, the mutation clusters which in¯uence dierent aspects of DNA binding may not be comparable. One would need to know which genes are essential for transforma-tion and what kB sites they contain in their promoters to compare directly the role of DNA binding altered by the N-RH mutations with the DNA binding altered by RH-C mutation cluster. Further, not all of the oncogenic mutations in each cluster may alter the same function of the protein. Indeed, the results in this manuscript demonstrated that the N-terminal env amino acids which strongly increase the transformation potential (Bhat and Temin, 1990; Garson et al., 1990) did not signi®cantly contribute to a change in DNA-binding speci®city by the N-RH mutation cluster. Furthermore, each mutation that change speci®city may increase (or decrease) the binding of the Rel protein to a dierent subset of kB sites. This may be one possible explanation why mutation Asp-82?Gly in the N-RH cluster which only weakly altered DNA-binding speci®city signi®cantly contributes to the transformation by v-Rel (Bhat and Temin, 1990; HrdlickovaÂ et al., 1994a) . The correlation can be, however, found between the DNA-binding function of speci®c RH-C mutations and their contribution to tumorigenesis. In the RH-C mutation cluster, the two mutations Arg-250?Gly and Glu-269?Ala which are principally responsible for the increased DNA binding are also able to contribute to transformation by Cterminally deleted c-Rel to a much greater extent than the other two mutations in this cluster (HrdlickovaÂ et al., 1994a and unpublished data) .
Consequences of v-Rel's altered kB DNA-binding properties and transformation
There are two hypotheses which attempt to explain how the expression of v-Rel alters the cellular regulatory mechanisms thereby leading to transformation. One hypothesis suggests that v-Rel interacts with DNA origins of replication and stimulates the replication apparatus of the cell . The second model proposes that oncogenic Rel proteins transform by altering the regulation of transcription of genes normally under the control of the Rel/NF-kB family (HrdlickovaÂ et al., 1994b; Sarkar and Gilmore, 1993) . Both these models require the explanation why highly oncogenic v-Rel interacts with promoters and/or replication origins dierently than weakly transforming c-Rel.
In this manuscript we propose one possible explanation by showing that the kB DNA-binding properties of v-Rel diers from properties of c-Rel and that the oncogenic mutations in three functional regions of c-Rel are responsible for these altered properties. Interestingly, mutations in dierent functional regions in¯uence dierent aspects of DNA binding. The mutations alter both DNA-binding speci®city and general binding ability of v-Rel to kB sites. The altered speci®city in DNA binding of v-Rel by the mutations in the N-terminus most likely leads to the inappropriate activation or repression of genes normally involves in controlled cell proliferation. Increased general DNA-binding ability provided by the mutations in the C-terminal region of the RHR may increase these modulatory activities. These mutations can also provide increased resistance to the inhibition of DNA binding by IkB-a (Diehl et al., 1993) . Finally, mutations in the transactivation domain may either serve for the regulation of v-Rel's DNAbinding ability under speci®c conditions or they might be selected for other functions that compensate for decreased DNA binding. The alterations in DNA binding of v-Rel may also in¯uence its proposed interactions with DNA origins of replication. These results suggest that the mutations present in v-Rel, which map to regions in c-Rel normally involved in the regulation of c-Rel's activity, alter the functions located in these regions and cause a conversion of a cellular protein to a highly transforming oncogene.
Materials and methods
The term`mutations in v-Rel' refers to changes in the primary structure of the Rel protein during the evolution of v-Rel from turkey c-Rel which resulted in speci®c dierences between the amino acid sequence of v-Rel and both turkey and chicken c-Rel.
DNA clones
Constructions of pv-rel2 and pc-rel2 plasmids were described previously (Nehyba et al., 1994) . pv-rel2 and pc-rel2 are pTZ-18R-based plasmids containing the v-rel coding region from pREV-T3 (Chen and Temin, 1982) and the chicken c-rel coding region from pBSc-rel#29 (Capobianco et al., 1990) , respectively. Hybrids between v-rel and c-rel, including pctt-rel, ptct-rel, pcct-rel, ptcc-rel, pctc-rel, pttc-rel were constructed using the common XhoI, HindIII, HindII and BssHII sites of pv-rel2 and pc-rel2 (HrdlickovaÂ et al., 1995a; Nehyba et al., 1994) . Plasmids pc-relde and pc-relgi encoding c-Rel mutants with double amino acid changes were constructed using the common HindIII, BamHI and HindII sites of pv-rel2 and pc-rel2 (HrdlickovaÂ et al., 1994a) . Plasmids pc-rela, pc-relb and pcrelc encoding c-Rel mutants with single amino acid changes were constructed by in vitro mutagenesis as described earlier (HrdlickovaÂ et al., 1994a) . pREV-TW, pREV-CTT, pREV-TCT, pREV-CCT and pREV-C were created by insertion of the Rel coding regions from pv-rel2, pctt-rel, ptct-rel, pcct-rel and pc-rel2, respectively, into the REVbased retroviral vector pREV-0, as described (HrdlickovaÂ et al., 1995a; Nehyba et al., 1994) . pCSV11S3 contains an infectious genome of CSV (Filardo et al., 1994) .
Construction of additional recombinant DNA clones
All recombinant DNA techniques were carried out using conventional procedures (Sambrook et al., 1989) . The Muta-Gene in vitro mutagenesis kit (Bio-Rad Laboratories, Inc., Richmond, Calif.) was used for oligonucleotide site-directed mutagenesis based on the method of Kunkel (1985) . Sequences of all plasmid regions subjected to in vitro synthesis in the site-directed mutagenesis procedure were veri®ed using a kit with Sequenase, version 2 (Promega, Madison, Wis.).
pc-relD118, containing the C-terminal deletion mutant of c-rel, was constructed from pc-rel2 in three steps. First, a TAG stop codon replacing c-Rel's amino acid 481 was created by site-directed mutagenesis using oligonucleotide 5'-CGTGAACATGtagACCAATGAC-3'. The stop codon is shown in lower case letters. The introduced diagnostic NspI restriction site enabling easy veri®cation of the construct is underlined. In the second step a double-stranded adapter 5'-CTAGTGCGCAGTGAGGATCCATGAG-3' (3'-ACGCGT-CACTCCTAGGTACTCGCGC-5') substituted the 347 bp SpeI ± BssHII fragment of unmutated pc-rel12. Diagnostic FspI and BamHI sites are underlined. In the third step, the 192 bp BstXI ± SpeI region of the plasmid constructed in the ®rst step replaced the corresponding part of the plasmid constructed in the second step creating the ®nal pc-relD118. pttc-relD118 was constructed by replacement of a 1341 bp XhoI ± BstXI region in pc-relD118 with a corresponding part of pttc-rel. penvc-rel was constructed by a reversion of mutation designated a in v-Rel by site-directed mutagenesis of pv-rel2 using the oligonucleotide 5'-CAAAGGGGTAtGCGTTTCAGA-3'. The mutagenesis changed Thr-29 to Met. A nucleotide which altered the code for the amino acid is in lower case letter. The same convention is used in all of the mutagenic oligonucleotides shown. The diagnostic six bp sequence that replaced and eliminated the MluI site of vrel is underlined. The XhoI ± ScaI fragment (175 bp) from mutated pv-rel2 was then recloned to substitute the analogous region of pc-rel2. pc-relabc was constructed by introduction of mutations a, b and c into c-Rel coded by the pc-rel2 plasmid. The mutation a was produced by sitedirected mutagenesis using oligonucleotide 5'-CAAAGGGGCAcGCGTTTCAGA-3'. This mutagenesis changed Met-20 to Thr. The diagnostic MluI site is underlined. Mutations b (Asp-82?Gly) and c (Arg-97?Glu) were introduced into cRel by replacing the 199 bp ScaI ± EcoRI region of pc-rel2 with an analogous fragment from pv-rel2. pc-relD118 and pttc-relD118 mutant rel genes were cloned into the pREV-0 vector using the common XhoI and BssHII sites. The resulting constructs were designated pREV-CD118 and pREV-TTCD118, respectively.
panti-c-rel was constructed in an analogous fashion as pcrel2. The HpaII fragment containing the coding sequence of chicken c-rel was inserted into the pTZ-18R-based plasmid in an opposite orientation than in pc-rel2.
Expression plasmid pATH-52.2 was constructed by insertion of the BglII ± BamHI fragment (643 bp) from pTZ52 into BamHI site of pATH-1 (Koerner et al., 1991) . pTZ52 encodes a C-terminally truncated version of chicken NF-kB2 (full cDNA was described by Sif and Gilmore, 1993) . Construction of pTZ52 will be described elsewhere.
Antibodies
HY87 monoclonal antibody was used to detect Rel proteins expressed from retroviral vectors (HrdlickovaÂ et al., 1994b) . Goat anti-mouse immunoglobulin antibodies conjugated with biotin were purchased from Southern Biotechnology Associates, Inc., Birmingham, Ala., and streptavidin coupled with alkaline phosphatase was obtained from Boehringer Mannheim, Corp., Indianopolis, Ind. Rabbit polyclonal antisera 1647, V1, VC and AL-1 used in electrophoretic mobility shift assays (EMSAs) were described previously (HrdlickovaÂ et al., 1995a; Kralova et al., 1994) . 1647, V1 and VC were raised against immunogens containing amino acids 2 ± 11, 115 ± 292 and 485 ± 503 of v-Rel, respectively. AL-1 was raised against an immunogen containing amino acids 1 ± 175 of chicken NFkB1. Rabbit polyclonal anti-p52.2 serum was raised against a trpE-fusion protein that contained amino acids 229 ± 437 of chicken NF-kB2. This fusion protein was produced in C600 Escherichia coli cells using expression plasmid pATH-52.2 described above. Anti-chicken c-Rel-speci®c rabbit antiserum 1096 was the kind gift of NR Rice. AntiChp65N rabbit antiserum raised against immunogen containing amino acids 1 ± 334 of chicken RelA was kindly provided by T Ikeda (Ikeda et al., 1993) .
Animals, cell lines and cell culture procedures SC chickens were hatched from embryonated eggs from Hyline International Hatcheries, Dallas Center, Iowa. DT95 is B-cell line established from an SC chicken bearing an avian leukosis virus-induced lymphoid tumor (Baba et al., 1985) . CEFs were prepared from 10 day old SC embryos using standard procedures. Cells were grown in Dulbecco's modi®ed Eagle's Medium supplemented with 5% bovine calf serum (HyClone Laboratories Inc., Logan, Utah), 5% chicken serum (Gibco Biologicals, Grand Island, NY), and antibiotics (penicillin and streptomycin, 100 U/ml and 50 mg/ml, respectively).
Rescue and characterization of REV-rel(CSV) viruses
The viruses are designated in this manuscript by the generic name REV-rel(CSV) or with speci®c names as shown in Figure 1c . All viral stocks were produced using CSV as a helper virus. Viruses were rescued by cotransfection of 30 mg DNA of the pREV-0-based construct (pREV-C, pREV-TW, pREV-CTT, pREV-TCT, pREV-CCT, pREV-CD118 or pREV-TTCD118) together with 1 mg of pCSV11S3 DNA into 5610 5 CEFs in a 100 mm diameter tissue culture dish. A modi®ed calcium phosphate transfection method (Chen and Okayama, 1987) was used and viruses were harvested 4 ± 7 days later. The infectious titer of a virus stock was measured in CEF cultures by an in situ expression assay as described in detail previously (HrdlickovaÂ et al., 1994b; Nehyba et al., 1994; Stoker and Bissell, 1987) . For all experiments, viruses were diluted so that cells were exposed to each Rel expressing virus at approximately the same multiplicity of infection. Analysis of transfected CEFs by Western transfer demonstrated that comparable levels of the Rel proteins were produced from all REV-rel viruses (data not shown). Further, this analysis, as well as an analysis of infected DT95 cells, also veri®ed that each of the viruses expressed Rel proteins of the expected size (data not shown).
Tumorigenesis assay
Five days old SC chickens were injected in the leg vein with virus containing 4610 4 IU of REV-rel(CSV). Control chickens were injected with 0.2 ml of CSV helper virus stock with a titer comparable to a CSV titer in stocks of REV-rel(CSV) viruses. Seven days after infection, a cell suspension was prepared from the spleen using a nylon mesh. For each 100 mg of spleen, 1 ml of culture medium was added. The suspension was allowed to settle for 15 s to remove large debris. Eight sixfold serial dilutions were prepared and cells were seeded in 96-well tissue culture trays (250 ml per well). Seven days after seeding, tumor cell growth was recorded and number of positive wells calculated as for a standard end-point dilution assay. Wells with at least 500 in vitro proliferating lymphoblastoid cells were considered positive. The total number of positive wells was calculated based upon the weight of the spleen and expressed as the number of tumor colony forming units (tCFU) per spleen.
In vitro transcription/translation
All Rel proteins were synthesized using pTZ-18R-based plasmids pv-rel2, pc-rel2, pctt-rel etc., described above. Transcription templates were prepared by linearization of the plasmids by BssHII. The proteins were produced using TNT 1 T7 coupled wheat germ extract system (Promega). 1 ± 2 mg of linearized DNA template were used per 50 ml reaction. Incorporation of [ 32 S]methionine was measured as suggested by the manufacturer of the TNT 1 transcription/ translation kit.
35 S-labeled proteins were diluted to an equal concentration with wheat germ extract based on measured [
35 S]methionine incorporation. Diluted proteins were run on an 8% SDS acrylamide gel (Laemli system), ®xed for 1 h in 45% methanol, 10% acetic acid, dried and subjected to autoradiography. Final adjustments of the concentrations were done based on results of the autoradiography. Molar concentration was then calculated considering the dierent number of methionines in the dierent Rel proteins. Unlabeled Rel proteins synthesized in parallel reactions were assumed to have the same concentration as their labeled counterparts. These unlabeled proteins were used for EMSAs. Mock in vitro translated wheat germ lysate (MTL) was used as a control for the background DNA-binding activity present in the wheat germ extract and as dilution buer for the unlabeled proteins used in the EMSA. MTL was obtained by coupled in vitro transcription-translation with a panti-c-rel DNA as a template. The concentration of the DNA template was always the same for both the MTL and the Rel translates in any particular experiment.
Nuclear extracts
Nuclear extracts were prepared from 5 to 10610 6 cells as described previously (HrdlickovaÂ et al., 1995a; Schreiber et al., 1989) . The nuclear extraction buer contained 20 mM N -2 -hydroxyethylpiperazine -N'-2-ethanesulfonic acid (HEPES) [pH 7.9], 400 mM KCl, 1 mM EDTA, 1 mM ethylene glycol-bis(b-aminoethyl ether)-N, N,N',N'-tetraacetic acid (EGTA), 15% glycerol, 1 mM dithiothreitol (DTT), 4 mM phenylmethylsulfonyl acid (PMSF). The extracts were aliquoted and stored at 7708C. The concentration of total protein was determined using the Bio-Rad Protein Assay Kit II (Bio-Rad Laboratories, Inc., Richmond, Calif.).
Western analysis
Western analysis was performed essentially as described previously (HrdlickovaÂ et al., 1994b) . Brie¯y, denatured proteins were separated on 8% SDS-polyacrylamide gel (Laemli system) using a Mini-PROTEAN II apparatus (Bio-Rad Laboratories, Inc.). Proteins were transferred to nitrocellulose in a semi-dry apparatus (Millipore Corporation, Bedford, Mass.) and sequentially reacted with monoclonal antibody HY87, goat anti-mouse IgG biotinylated antibody and streptavidin-linked alkaline phosphatase (Boehringer Mannheim, Corp., Indianapolis, Ind.). Proteins were visualized by an enzymatic reaction using 5-bromo-4-chloro-3-indolyl phosphate and 4-nitro blue tetrazolium chloride as substrates (Boehringer Mannheim, Corp.). Biotinylated molecular weight markers from BioRad Laboratories were used. Scanned images of the stained blots were quantitated using public domain software NIH Image, Version 1.55.
EMSAs
For DNA-binding assays, the composition of binding buer was as follows: 20 mM Tris-HCl [pH 7.4], 0.04 mM EDTA, 0.1 M KCl, 5% glycerol, 1 mg/ml acetylated BSA, 0.1% Nonidet P-40, 1 mM DTT and 1 mM PMSF. To saturate nonspeci®c DNA-binding activity, 1 mg of poly [dCdI] . poly[dCdI] (Sigma Chemical Company, St. Louis, Missouri) was added to each 2 ml of wheat germ translation reaction or to each aliquot of the nuclear extract containing 8 mg of total protein. 0.5 fmol of in vitro generated Rel protein or 8 mg of nuclear extract combined with 45 000 to 70 000 c.p.m. of DNA probe were used per lane unless indicated otherwise in the description of the particular experiment. The Rel proteins were preincubated with poly [dCdI] . poly [dCdI] in ice cold buer for 5 min. After the addition of radioactively labeled oligonucleotide, the reaction was incubated for 45 min on ice. This time and temperature allowed the reaction to achieve an equilibrium. During the 45 min of incubation the DNA-binding complexes were stable (data not shown). For supershift experiments, 2 ml of rabbit antiserum was added and the incubation was continued for 15 min at 258C. The complexes were separated from the free DNA probe by electrophoresis through a 4% polyacrylamide gel in 0.56TBE (TBE is 0.09 M Tris-borate, 2 mM EDTA [pH 8.0]). The gels were run at room temperature for 3 to 4 h, ®xed for 5 min in 45% methanol, 10% acetic acid, dried and then analysed by autoradiography or by a Phosphorimager 445SI (Molecular Dynamics, Sunnyvale, Calif.).
DNA probes for EMSAs
Oligonucleotide probes were prepared by annealing of a primer 5'-AGCTCAAGC-3' to oligonucleotide templates followed by primer extension with the Klenow fragment of DNA polymerase I (Boehringer Mannheim, Corp.) in the presence of [a- 32 P]dCTP. The following templates were used: 5'-AATTCAGGGGAATTCCCCTAAGCTTGAG-CT-3' containing a palindromic variant of the IL-2R kB site (IL-2R kB-pd) (Ballard et al., 1990) , 5'-AATT-CACGGGGGTTCCCATAAGCTTGAGCT-3' containing avian MHC class I promoter kB site (Kroemer et al., 1990) and 5'-AATTCACGGGAAATTCCCTAAGCTT-GAGCT-3' containing avian c-rel promoter kB site Hannink and Temin, 1990) . The underscore identi®es the actual kB site. The unincorporated radioactivity was removed using a G-25 Sephadex column. We found that probes prepared under these conditions were resolved by EMSA polyacrylamide gel into three closely migrating species (see Figure 2a) . Only the slowest migrating species was able to bind to the Rel proteins (de®ned as active probe). This fact, not apparent from Figure 2a , where the probe was used in excess to avoid saturation of reaction with protein, was established by actually measuring the amount of all three probe species by a Phosphorimager 445SI (Molecular Dynamics). A decrease in the amount of active probe species combined with no change in the amount of the other two more mobile probe species was also seen directly on autoradiograms when a large excess of the Rel protein over the kB DNA probes was used (data not shown). The amount of active probe in each particular EMSA experiment was determined using a Phosphorimager 445SI (Molecular Dynamics) and is shown as a relative number which compares the amount of the active probe with the MHC class I kB site or the c-rel kB site to active probe with the IL-2R kB-pd site in binding reactions that did not contain the Rel proteins (MTL control). Quantities of bound probe determined by a Phosphorimager (Table 1) were corrected by dividing the measured values by the above mentioned relative number based on the assumption (veri®ed for IL-2R kB-pd and MHC class I kB probes in the experiment shown in Figure 3 ) that the amount of bound probe increases linearly with the amount of active probe applied within the concentration limits used in described experiments.
Competition experiments
The speci®city of DNA binding was veri®ed by the addition of competitor oligonucleotides into the binding reaction. Double stranded competitor oligonucleotide containing the IL-2R kB-pd site was obtained by annealing of the oligonucleotide template with this site (described above) with complementary oligonucleotide 5'-CAAGCTTAGGGGAATTCCCCTG-3'.
kB-unrelated double stranded oligonucleotide designated CLK was obtained by annealing of a oligonucleotide 5'-CG-CGCAGCTTATCGATGATAAGGTACCGTCAC-3' with complementary oligonucleotide 5'-TCGAGTGACGG-TACCTTATCATCGATAAGCTG-3'. Binding was considered speci®c when the kB unrelated double stranded CLK oligonucleotide in 250 times excess was unable to compete with the labeled IL-2R kB-pd probe while the same amount of unlabeled IL-2R kB-pd oligonucleotide almost completely (less than 5% of bound labeled probe remained) competed the same labeled probe.
